HEMOPATCH Trademark

Trademark Overview

On Friday, April 29, 2016, a trademark application was filed for HEMOPATCH with the United States Patent and Trademark Office. The USPTO has given the HEMOPATCH trademark a serial number of 87019334. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 28, 2019. This trademark is owned by Baxter International Inc.. The HEMOPATCH trademark is filed in the Pharmaceutical Products category with the following description:

PHARMACEUTICAL PRODUCT, NAMELY, A HEMOSTATIC AGENT FOR SURGICAL USE
hemopatch

General Information

Serial Number87019334
Word MarkHEMOPATCH
Filing DateFriday, April 29, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 28, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 2, 2016

Trademark Statements

Goods and ServicesPHARMACEUTICAL PRODUCT, NAMELY, A HEMOSTATIC AGENT FOR SURGICAL USE

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 4, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBaxter International Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDeerfield, IL 60015
Party NameBaxter International Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDeerfield, IL 60015

Trademark Events

Event DateEvent Description
Monday, October 28, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 28, 2019ABANDONMENT - NO USE STATEMENT FILED
Friday, March 29, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 28, 2019EXTENSION 5 GRANTED
Tuesday, March 26, 2019EXTENSION 5 FILED
Tuesday, March 26, 2019TEAS EXTENSION RECEIVED
Tuesday, October 23, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 22, 2018EXTENSION 4 GRANTED
Thursday, September 27, 2018EXTENSION 4 FILED
Thursday, October 18, 2018NOTICE OF REVIVAL - E-MAILED
Thursday, October 18, 2018EXTENSION RECEIVED WITH TEAS PETITION
Thursday, October 18, 2018PETITION TO REVIVE-GRANTED
Thursday, October 18, 2018TEAS PETITION TO REVIVE RECEIVED
Thursday, March 8, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 6, 2018EXTENSION 3 GRANTED
Tuesday, March 6, 2018EXTENSION 3 FILED
Tuesday, March 6, 2018TEAS EXTENSION RECEIVED
Tuesday, September 26, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 22, 2017EXTENSION 2 GRANTED
Friday, September 22, 2017EXTENSION 2 FILED
Friday, September 22, 2017TEAS EXTENSION RECEIVED
Wednesday, May 10, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 9, 2017EXTENSION 1 GRANTED
Monday, March 27, 2017EXTENSION 1 FILED
Thursday, May 4, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, April 8, 2017NOTICE OF REVIVAL - E-MAILED
Friday, April 7, 2017EXTENSION RECEIVED WITH TEAS PETITION
Friday, April 7, 2017PETITION TO REVIVE-GRANTED
Friday, April 7, 2017TEAS PETITION TO REVIVE RECEIVED
Tuesday, September 27, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 2, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 2, 2016PUBLISHED FOR OPPOSITION
Wednesday, July 13, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, June 23, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 23, 2016ASSIGNED TO EXAMINER
Wednesday, May 4, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, May 3, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

hemopatch agent surgical hemostatic namely product pharmaceutical